|
Volkova S.B., Podymova A.S.
Experience with the HIV protease inhibitor fosamprenavir in russian practice
|
№4 / 2013
|
|
Sundukov A.V., Gafurov Yu.T., Evsyukov O. A.
Clinical and laboratory features of abnormalities in the cervix uteri, external genitals, and vagina in HIV-infected patients
|
№4 / 2013
|
|
Pyadushkina E.A., Andreeva N.S., Omelyanovsky V.V., Avxentyeva M.V., Rebrova O.Yu.
Сlinicoeconomic analysis of the use of kivexa in the first-line antiretroviral therapy of HIV infection in the Russian Federation
|
№3 / 2013
|
|
Kravchenko A.V., Kanestri V.G.
Use of the fusion inhibitor enfuvirtide in antiretroviral therapy regimens for HIV-infected patients
|
№1 / 2013
|
|
Kanestri V.G.
The novel HIV non-nucleoside reverse transcriptase inhibitor rilpivirine: a review of international clinical trials
|
№3 / 2012
|
|
Kravchenko A.V., Kanestri V.G.
The HIV nucleoside reverse transcriptase inhibitors abacavir and lamivudine in first-line antiretroviral therapy regimens
|
№2 / 2011
|
|
Kravchenko A.V., Zimina V.N., Viktorova I.B., Sitdykova Yu.R.
Manifestation of immune reconstitution inflammatory syndrome during antiretroviral therapy in patients with HIV infection
|
№1 / 2011
|
Русский
